Cancer / Oncology
GenomOncology Selected by Personalis to Support MRD and SNV Analysis for NeXT Personal™ Assay
NeXT Personal delivers industry-leading sensitivity to detect MRD and cancer recurrence at the earliest timepoints. The assay tracks and annotates individu...
July 13, 2022 | News
ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment
TLX250-CDx, which has received "Breakthrough Designation" from the U.S. Food and Drug Administration (FDA)1, is being developed as an imaging agent for use...
July 11, 2022 | News
Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System
Lunit and FujiFilm Thailand to supply Lunit INSIGHT CXR and Lunit INSIGHT MMG to one of SEA's largest hospital using Microsoft Azure Aim to detect cance...
July 05, 2022 | News
Seoul National University Hospital selects RayCare to advance oncology system
In April 2022 the carbon ion center at SNUH ordered RayStation treatment planning system, for use with their Toshiba Heavy Ion Therapy System. Th...
July 04, 2022 | News
GSK's Zejula (niraparib) Tablet approved in Singapore for first-line and recurrent monotherapy maintenance treatment in advanced ovarian cancer
GlaxoSmithKline (GSK) Singapore today announced that Health Sciences Authority has approved Zejula (niraparib) Tablet, an oral, on...
June 29, 2022 | News
Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies
Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry’s largest manufacturer...
June 24, 2022 | News
Australia’s PrOSPeCT Project Is Sequencing Thousands of Cancer Patients
This March, Australia launched the Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT), which will sequence the genomes of more t...
June 23, 2022 | News
Illumina launches a research test developed in collaboration with Merck to better understand the genome of tumors
llumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and analytics-based technologies, announced the launch of a research test develo...
June 23, 2022 | News
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients Priority Review requested; if accepted, anticipate an 8-mont...
June 23, 2022 | News
JNCCN: Mismatch in Breast Cancer Trial Results and Real-World Outcomes Based on Treatment Discontinuation
New research in the June 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network raises issues with clinical tri...
June 22, 2022 | News
DTx Leader Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Cancer
International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), today announces an integrated digital therape...
June 20, 2022 | News
Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute
Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovatio...
June 17, 2022 | News
Nonagen Bioscience announces CE mark for Oncuria® bladder cancer diagnostic
Oncuria is the first-of-its-kind multiplex urine test for the quantitative detection of 10 biomarkers in urine that are associated with the presence of...
June 17, 2022 | News
WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies
WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and Wugen Inc., a clinical-stage biotech...
June 16, 2022 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
